2023 annual financial data

Estrella Immunopharma 2023 Operating margin

Direct answer

Operating margin was Not calculable.

Operating income was -7.31M USD and net income was -7.31M USD.
Operating cash flow was -16.07M USD.

Get free Estrella Immunopharma email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-7.31M USD
Net income
-7.31M USD
Operating cash flow
-16.07M USD